Navigation Links
Microbix Biosystems Provides a Corporate Update
Date:10/29/2009

    - Influenza: 50/50 joint venture agreement signed with Hunan
      Biopharmaceutical to build Asia's largest seasonal and pandemic flu
      manufacturing facility
    - Biologics: 23% growth in sales and to soon become cash-flow positive
    - Thrombolytic: Nears licensing and sales of KINLYTIC(TM) thrombolytic
      agent for pulmonary embolism
    - Semen sexing: 25% of the dairy semen collection centres now under
      agreement
    - Dr. Mark Cochran added to management team

TORONTO, Oct. 29 /PRNewswire-FirstCall/ - Microbix Biosystems Inc. (MBX:TSX) a virology and biological technology company with a near-term pipeline of proprietary products, today provided an update on its corporate activities.

For the fiscal year ended September 30, 2009, Microbix reported revenues of $6 million, a 23 percent increase over the previous year (unaudited), in its core business of providing biological products to the diagnostic and research industries. Continued growth in the core business will result in the Company becoming cash-flow positive in the very near future, reducing the need for other financings that dilute shareholder value.

William J Gastle, Microbix chairman and CEO, said, "In 2010, Microbix will be poised to take the largest step forward in its 20-year history. This growth will be fuelled by our announcement this week that the company has completed the initial financing for our joint venture with Hunan to build the world's third largest influenza vaccine facility; the approval of KINLYTIC in Canada and other markets, and partnership agreements for our semen sexing technology (SST) for livestock management. We have strong opportunities for growth in new areas with a growing and profitable base business serving the medical diagnostic industry."

Microbix continues to invest wisely in its core business such as its new Watline production facility which has improved efficiency, capacity, and capability a
'/>"/>

SOURCE Microbix Biosystems Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase
2. Microbix Uses Core Business Cashflow To Fund Late-Stage Pipeline To Build Shareholder Value In 2009
3. Microbix First Quarter Sales Grow Over 50% With Continued Progress On The Pipeline
4. Microbix Announces A New Technology Platform For The SST Project
5. Microbix Sales Grow Over 30% In The Second Quarter; Up 43% In The First Half 09
6. Microbix Files First Patent Applications On Novel Technology Platform For Large Semen Sexing Market
7. Microbix Sales Grow 22% For Nine Months
8. Microbix And Hunan Biopharmaceutical To Build Asias Largest Influenza Vaccine Facility
9. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
10. Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute
11. Primera Biosystems Raises $21 Million in Series B Private Round
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Oct. 22, 2014 Research and ... "Global DNA Diagnostics Market (Product types, Application, ... Global Trends, Company Profiles, Demand, Insights, Analysis, Research, ... report to their offering. ... applications, techniques, end users and Geography) Global Size, ...
(Date:10/22/2014)... 22, 2014 Involution Studios , ... of a new infographic, Understanding Ebola . ... beautifully designed, easy to follow informative tool for anyone ... outbreak, symptoms and prevention. , "As the news has ... 2014 Ebola outbreak represents not only a healthcare crisis ...
(Date:10/22/2014)... According to new market research report ... Integration, Deployment & Support), by Service Model (SaaS, ... Others (Hybrid & Community)) - Global Forecast to ... Cloud Professional Services Market into various sub-segments with ... also identifies the drivers and restraints for this ...
(Date:10/22/2014)... KONG , Oct. 22, 2014  aTyr Pharma ... that rare disease expert John C. McKew , ... McKew brings more than two decades of expertise in ... Institutes of Health, Wyeth Research and Genetics Institute, Inc. ... aTyr,s efforts to expand and translate its novel Physiocrine ...
Breaking Biology Technology:Global DNA Diagnostics Market (Product types, Application, Technology, End User and Geography) - Forecast to 2020 2Global DNA Diagnostics Market (Product types, Application, Technology, End User and Geography) - Forecast to 2020 3Involution Studios' Ebola Infographic Provides Key Disease Information and Statistics at a Glance 2Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 2Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 3Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 4Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 5aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3
... RIDGE, Tenn., Feb. 4, 2010 -- Four Oak Ridge ... will receive five-year research grants as part of the ... The $85 million program, funded under the American Recovery ... is designed to support exceptional researchers during the crucial ...
... , ... and HEALTHeCAREERS Network , leading employment communities for ... career sites recently recognized by recruiters and job seekers. , ... ) , The same audiences have chosen Hcareers for the ...
... ... Opportunities and Challenges of Maize Cultivation Under Dry Conditions , ... Bordeaux, France (Vocus) February 4, 2010 -- ... develop drought-tolerant crops, which will play a major role in sustainably increasing agricultural productivity, ...
Cached Biology Technology:4 ORNL researchers selected for Recovery Act early career funds 24 ORNL researchers selected for Recovery Act early career funds 3Industry Web Sites Continue to Win Online Award 2Industry Web Sites Continue to Win Online Award 3DuPont Leader: Drought-Tolerant Crops Developed Through Modern Breeding are Key to Sustainably Increasing Grain Production 2
(Date:10/17/2014)... Why do male ... reproduce? And why are there two sexes anyway? These and ... the research journal Molecular Human Reproduction published today ... University Bielefeld has compiled this special issue on sperm competition. ... copulate with several males in quick succession – chimpanzees are ...
(Date:10/16/2014)... synthesis of recent research findings to inform their management ... states. , The Ecology and Management of Moist ... of the Relevant Biophysical Science and Implications for Future ... U.S. Forest Service,s Pacific Northwest Research Station, is a ... synthesis of the large body of scientific information on ...
(Date:10/16/2014)... October 16, 2014 NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile ... technologies including Wocket™, the Smart Wallet, at the 13 ... is a leading global conference on the intersection of ... Mark Anderson , founder and publisher of the ...
Breaking Biology News(10 mins):Sperm wars 2New report synthesizes best available science on management of moist mixed-conifer forests 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 3
... the brain play a role as an electric wire ... connected with various joints (synapse), various brain functions can ... receives the signals with many synapses located on those ... received signals. The research team of Associate Professor Kubota ...
... from the Center for Applied Medical Research (CIMA) of ... 1, a protein synthesized by muscle cells and adipose ... metabolism. "These new findings add to those we already ... effects showed in acute liver damage and solid organ ...
... Research will host its Second AACR International Conference on Frontiers ... from Sept. 14-18, 2011. This conference is an ... breakthroughs that will expedite the development of lifesaving cancer therapeutics ... truly in an exciting period for cancer research, as work ...
Cached Biology News:A 3-D reconstructed image of neural dendritic trees using the advanced electron microscope technology 2Cardiotrophin 1 shows promising results for treatment of obesity and metabolic syndrome 2
... ISO 9001:2000 Certified USDA Research Registered ... SOP's Training AALAS Certified Technicians ... Procedures GLP Documentation Upon Request Focus ... point for all your custom immunology service ...
...
...
Peptide-affinity Purified Polyclonal Antibody to Sphingolipid Receptor Edg8/S1P5...
Biology Products: